Related Experiment Video
Updated: Aug 1, 2026

Magnetic Resonance Derived Myocardial Strain Assessment Using Feature Tracking
Published on: February 12, 2011
A novel deep learning system for STEMI prognostic prediction from multi-sequence cardiac magnetic resonance
Yifan Chen1, Meng Jiang1, Chao Xia2
1Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Insights
DeepSTEMI, a deep learning system, accurately predicts major adverse cardiovascular events after myocardial infarction using cardiac MRI and clinical data. This AI tool improves risk stratification for better patient outcomes.
Area of Science:
- Cardiology
- Artificial Intelligence
- Medical Imaging
Background:
- ST-elevation myocardial infarction (STEMI) poses significant cardiovascular risks.
- Current risk scores and imaging biomarkers have limited accuracy for predicting post-STEMI outcomes.
- Accurate early risk stratification is crucial for personalized treatment strategies.
Purpose of the Study:
- To develop and validate DeepSTEMI, an AI system for predicting 2-year major adverse cardiovascular events (MACE) after STEMI.
- To integrate multi-sequence cardiac magnetic resonance (CMR) images with clinical data for enhanced risk prediction.
- To compare DeepSTEMI's performance against existing clinical risk scores and manual imaging biomarkers.
Main Methods:
- Developed an end-to-end deep learning system (DeepSTEMI) with U-Net for segmentation and Transformer for prediction.
- Utilized a multicenter dataset (n=610) from the EARLY-MYO-CMR registry for development.
- Externally validated the system in 334 patients from three independent cardiac centers.
Main Results:
- DeepSTEMI demonstrated superior predictive performance in external validation (AUC 0.894, accuracy 94.3%).
- The model identified high-risk patients with a 20-fold increased MACE risk.
- SHAP analysis confirmed clinical-imaging synergy, and DeepSTEMI outperformed the Eitel score across subgroups.
Conclusions:
- DeepSTEMI offers an automated, scalable, and interpretable solution for post-STEMI risk stratification.
- The system advances cardiovascular risk prediction beyond current limitations.
- DeepSTEMI shows particular benefit in women and patients imaged 4-7 days post-STEMI.
Abstract:
ST-elevation myocardial infarction (STEMI) remains a leading cause of cardiovascular morbidity and mortality worldwide, and accurate early risk stratification is critical for implementing precision therapies in clinical practice. However, existing clinical risk scores and manually derived imaging biomarkers have limited accuracy in predicting post-STEMI outcomes. To address this gap, we developed DeepSTEMI, an end-to-end deep learning system that integrates multi-sequence cardiac magnetic resonance (CMR) images with clinical parameters for predicting 2-year major adverse cardiovascular events (MACE). The system comprised two key algorithmic modules: a U-Net module that automatically segments heart regions from raw CMR images and a Transformer-based module that predicted future cardiovascular events. DeepSTEMI was developed using a multicenter dataset (n = 610; 20,618 images) from STEMI patients enrolled in the EARLY-MYO-CMR registry (NCT03768453), with external validation performed in 334 patients (9944 images) from three independent cardiac centers. In external validation, DeepSTEMI demonstrated superior predictive performance compared to conventional clinical risk scores and manual CMR parameters (AUC 0.894, 95% CI: 0.823-0.965; overall accuracy 94.3%). The model identified high-risk patients who exhibited a 20-fold MACE risk compared to low-risk counterparts (HR 20.43, log-rank P < 0.001). SHapley Additive exPlanations (SHAP) analysis revealed that DeepSTEMI's predictive power stems from clinical-imaging synergy, enabling it to capture complex pathological patterns. DeepSTEMI achieved consistently superior performance over the Eitel score across all subgroups, with the greatest benefit observed in women (NRI 1.597) and in patients imaged 4-7 d post-STEMI (NRI 1.442). Overall, DeepSTEMI serves as an automated, scalable, and interpretable clinical copilot, which advances post-STEMI risk stratification beyond the limitations of current paradigms.
More Related Videos
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022